LETLIV SYRUP is a combination of Cyproheptadine and Tricholine Citrate, which belong to the groups of medicines called antihistamines and bile acid-binding agents, respectively. It is used to manage loss of appetite, weight loss and anorexia nervosa (an eating disorder). It is also used to manage weight gain in anti-tubercular and antiretroviral regimens.
In children, it is used for gaining weight, having an inadequate dietary intake or loss of appetite or suffering from anaemia, liver disease or digestive disorders. It is also used to manage allergic rhinitis and conjunctivitis, migraine, asthma and hepatic disorders. Appetite loss is a state in which an individual has no desire to eat food, which leads to a deficiency of essential and non-essential nutrients that are required for the proper metabolism and growth of the body.
LETLIV SYRUP is not recommended for use in patients who have or had angle-closure glaucoma, stenosing peptic ulcer, symptomatic prostatic hypertrophy, bladder neck obstruction or pyloroduodenal obstruction. Alcohol should be avoided during LETLIV SYRUP management because it may increase the LETLIV SYRUP's action.
Before taking this medicine, tell your physician if you have a history of bronchial asthma, increased intraocular pressure, hyperthyroidism, cardiovascular disease, liver problems, kidney problems or hypertension. LETLIV SYRUP is not recommended for use by pregnant or breastfeeding women. It should be recommended for use in children and adolescents (below 18 years of age).
The most common side effects of taking this medicine are drowsiness, dizziness, insomnia, blurred vision, loss of coordination, skin rash, gastrointestinal upset, nausea or vomiting. Contact your physician if the symptoms worsen.
No content available
